Clinical Trial Update: Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

View source ↗

Summary

A clinical trial update notes a study on predicting recurrence in low-risk endometrial cancer patients with FIGO grade 1–2 endometrioid adenocarcinoma, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Endometrioid Adenocarcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING